Remote health kiosk at innovation event in Boston May 1-3
VANCOUVER, BC, — (April 27, 2022) – UniDoc Health Corp. (CSE: UDOC) (FRA: L7T) (OTCQB: UDOCF) (“UniDoc,” or the “Company”), an innovator in the telehealth sector, is pleased to announce its participation and product launch at ATA2022, booth 1202, during the world’s largest telehealth innovation event held in Boston, Massachusetts May 1 to 3, 2022.
The event is produced by the American Telemedicine Association, which was founded in 1993 and is a non-profit association headquartered in Washington D.C. The ATA includes more than 400 organizations focused on transforming health and care through enhanced, efficient delivery. ATA2022 is the organization’s 26th Annual Conference & Expo where providers, technology developers, business professionals and leaders from across the healthcare sector convene to hold in-depth, thoughtful, and critical discussions about the future of health.
During this year’s event at the Boston Exhibition & Convention Center (BCEC) UniDoc Health will unveil the “H3 Cube” at its affiliate partner AMD Global Telemedicine Inc. booth 1202. The H3 Cube is a custom fabricated kiosk designed for telehealth delivery in commercial partner locations. Company representatives will be in attendance to elaborate upon UniDoc’s Virtual Care Solutions Model relative to business opportunities for potential licensees, medical practitioners, and insurers.
The customizable, and comprehensive H3 Cube telehealth solution integrates cloud-based services and analytical tools, along with access to the Company’s developing network of healthcare providers, pharmacies, and hospitals. The telehealth capability provides patients with a live virtual visit with a healthcare professional utilizing fully integrated medical devices within a controlled environment in locations such as pharmacies, community centres, or care facilities.
Company CEO & President Antonio Baldassarre notes, “We are excited to have this opportunity to come together with the telehealth community as we launch our new H3 Cube into the marketplace. Plus, a big thank you to our partners at AMD Global Telemedicine for hosting our launch during the event. We have worked hard to get to this point, and we hope to build upon our efforts through the introduction of our business to the association membership and beyond. We look forward to meeting up with many old friends and in meeting and making new relationships that will help propel UniDoc Health towards future commercial success.”
We invite anyone interested in our venture to visit our website at www.unidoctor.com and signup to receive the timely updates regarding our activities, events, and progress. You are also invited to join us on social media with Facebook, Twitter or Instagram.
On Behalf of The Board of Directors,
CEO, President & Director
UniDoc Health Corp. (CSE: UDOC)
About UniDoc Health Corp. (CSE: UDOC) (FRA: L7T) (OTCQB: UDOCF)
UniDoc is developing a telehealth solution which is being designed as a self-contained remote virtual clinic within a private kiosk for patients to undergo full consultations as if they were present in a physician’s office. Telehealth opens the doors to a large segment of the population challenged by access, experience or understanding of online computer technology. It is the Company’s belief that physical accessibility is the key to its business proposition. UniDoc is dedicated to unlocking shareholder value by delivering an excellent product and sophisticated commercial network within an expedited timeframe. The UniDoc team encourages engagement, questions, and interest, so please stay in touch and invite anyone who might be interested in our story to visit our website at www.unidoctor.com and signup to receive the latest information with updates on our activities, events and progress. You are also invited to join us on social media with Facebook, Twitter or Instagram.
For further information, please contact
UniDoc Investor Relations
Tel: +1 778.383.6731
Matt Chatterton, Director
Tel: +1 778.613.2082
This news release contains statements and information that, to the extent that they are not historical fact, may constitute “forward-looking information” within the meaning of applicable securities legislation. Forward-looking information may include financial and other projections, as well as statements regarding future plans, objectives, or economic performance, or the assumption underlying any of the foregoing. In some cases, forward-looking statements can be identified by terms such as “may”, “would”, “could”, “will”, “likely”, “except”, “anticipate”, “believe”, “intend”, “plan”, “forecast”, “project”, “estimate”, “outlook”, or the negative thereof or other similar expressions concerning matters that are not historical facts. Examples of such statements include, but are not limited to, statements with respect to the Company’s participation at ATA2022 and the commercial launch of the H3 Cube.
Forward-looking information is based on the assumptions, estimates, analysis, and opinions of management made in light of its experience and its perception of trends, current conditions and expected developments, as well as other factors that management believes to be relevant and reasonable in the circumstances at the date that such statements are made, but which may prove to be incorrect. The material factors and assumptions used to develop the forward-looking information contained in this news release include, but are not limited to, key personnel and qualified employees continuing their involvement with the Company; the Company’s ability to secure additional financing on reasonable terms; the competitive conditions of the industries in which the Company operates; and laws and any amendments thereto applicable to the Company.
Forward-looking information involves known and unknown risks, uncertainties and other factors that may cause the actual results, performance or achievements of the Company to differ materially from any future results, performance or achievements expressed or implied by the forward-looking information, including, without limitation, risks relating to the future business plans of the Company; risks that the Company will not be able to retain its key personnel; risks that the Company will not be able to secure financing on reasonable terms or at all, as well as all of the other risks as described in the Company’s final prospectus dated December 2, 2021 under the heading “Risks Factors.” Accordingly, readers should not place undue reliance on any such forward-looking information. Further, any forward-looking information speaks only as of the date on which such statement is made. New factors emerge from time to time, and it is not possible for the Company’s management to predict all such factors and to assess in advance the impact of each such factor on the Company’s business or the extent to which any factor, or combination of factors, may cause actual results to differ materially from those contained in any forward-looking information. The Company does not undertake any obligation to update any forward-looking information to reflect information or events after the date on which it is made or to reflect the occurrence of unanticipated events, except as required by law, including securities laws.
The CSE does not accept responsibility for the adequacy or accuracy of this release.